Liver Diseases  >>  Ixempra (ixabepilone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ixempra (ixabepilone) / Otsuka, R-Pharm, Allarity Therap
NCT00023946: BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Terminated
2
50
US
ixabepilone, BMS-247550, epothilone B lactam, Ixempra, laboratory biomarker analysis
National Cancer Institute (NCI)
Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Localized Extrahepatic Bile Duct Cancer, Localized Gallbladder Cancer, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
07/05
11/09

Download Options